[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors
Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and�…
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and�…
American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update
L Blonde, GE Umpierrez, SS Reddy, JB McGill…�- Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes�…
evidence-based recommendations for the comprehensive care of persons with diabetes�…
American Association of Clinical Endocrinology Consensus Statement: comprehensive type 2 diabetes management algorithm–2023 update
SL Samson, P Vellanki, L Blonde, EA Christofides…�- Endocrine Practice, 2023 - Elsevier
Objective This consensus statement provides (1) visual guidance in concise graphic
algorithms to assist with clinical decision-making of health care professionals in the�…
algorithms to assist with clinical decision-making of health care professionals in the�…
[HTML][HTML] Est�ndares SEA 2022 para el control global del riesgo cardiovascular
Resumen La Sociedad Espa�ola de Arteriosclerosis tiene entre sus objetivos contribuir al
mayor y mejor conocimiento de la enfermedad vascular, su prevenci�n y su tratamiento. Es�…
mayor y mejor conocimiento de la enfermedad vascular, su prevenci�n y su tratamiento. Es�…
Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week
S Tsimikas, SM Marcovina�- Journal of the American College of Cardiology, 2022 - jacc.org
This study reviews ancestral differences in the genetics of the LPA gene, risk categories of
elevated lipoprotein (a)[Lp (a)] as defined by guidelines, ancestry-specific Lp (a) risk�…
elevated lipoprotein (a)[Lp (a)] as defined by guidelines, ancestry-specific Lp (a) risk�…
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo�…
ABSTRACT Non-fasting lipidemia (nFL), mainly contributed by postprandial lipidemia (PL),
has recently been recognized as an important cardiovascular disease (CVD) risk as fasting�…
has recently been recognized as an important cardiovascular disease (CVD) risk as fasting�…
[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022
HE Bays, A Agarwala, C German, P Satish…�- American Journal of�…, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding�…
about ten cardiovascular disease risk factors–2022" is a summary document regarding�…
Lipoprotein (a) testing trends in a large academic health system in the United States
HS Bhatia, S Hurst, P Desai, W Zhu…�- Journal of the American�…, 2023 - Am Heart Assoc
Background Despite its high prevalence and clinical significance, clinical measurement of
lipoprotein (a) is rare but has not been systematically quantified. We assessed the�…
lipoprotein (a) is rare but has not been systematically quantified. We assessed the�…
[HTML][HTML] Obesity and dyslipidemia
KR Feingold - 2015 - europepmc.org
Abnormalities in lipid metabolism are very commonly observed in patients who are obese.
Approximately 60-70% of patients with obesity are dyslipidemic. The lipid abnormalities in�…
Approximately 60-70% of patients with obesity are dyslipidemic. The lipid abnormalities in�…
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data�…
Aim To evaluate the effect of bempedoic acid on glycaemic and lipid variables in patients
with hypercholesterolaemia. Methods A patient‐level pooled analysis of four phase 3�…
with hypercholesterolaemia. Methods A patient‐level pooled analysis of four phase 3�…